Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Intertech Bio-Technology is a Taiwan-based biotechnology company specializing in the research, development, and manufacture of probiotic strains and microbial products. Founded in 2002, the company leverages advanced microbial fermentation and stabilization technologies to produce high-potency probiotics for human health, animal nutrition, and environmental applications. Their human health portfolio focuses on gastrointestinal wellness, immune system modulation, and allergy management through proprietary strains like Lactobacillus and Bifidobacterium. Intertech Bio operates state-of-the-art manufacturing facilities that comply with international quality standards, providing OEM and ODM services to global nutraceutical and functional food brands. The company is committed to scientific innovation, maintaining active research programs to identify and characterize novel microbial candidates for diverse therapeutic and nutritional needs.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Intertech Bio.